Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 804

Results For "RAT"

9466 News Found

Biosion appoints Joel Edwards as Chief Business Officer
People | February 22, 2022

Biosion appoints Joel Edwards as Chief Business Officer

Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.


Daewoong Pharmaceutical posts strong financials in 2021
News | February 22, 2022

Daewoong Pharmaceutical posts strong financials in 2021

Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.


Solvay invests in Zurich-based 3D printing startup
Startup | February 22, 2022

Solvay invests in Zurich-based 3D printing startup

9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare


PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery
People | February 22, 2022

PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery

He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,


Formulated Solutions appoints John Maddox as COO
People | February 22, 2022

Formulated Solutions appoints John Maddox as COO

John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida


Thermo Scientific offers a new portfolio of chromatography and mass spectrometry consumables
Medical Device | February 22, 2022

Thermo Scientific offers a new portfolio of chromatography and mass spectrometry consumables

The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets


World’s first clinical trial for 3D bioprinted stem cell vascular grafts in China
Biotech | February 22, 2022

World’s first clinical trial for 3D bioprinted stem cell vascular grafts in China

Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.


CARsgen Therapeutics opens new U.S. cGMP facility for CAR T production
News | February 22, 2022

CARsgen Therapeutics opens new U.S. cGMP facility for CAR T production

The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe


Abbott's CardioMEMS HF System receives USFDA approval
Medical Device | February 22, 2022

Abbott's CardioMEMS HF System receives USFDA approval

New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure